Shahnaz Sali

633 total citations
44 papers, 287 citations indexed

About

Shahnaz Sali is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Shahnaz Sali has authored 44 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 20 papers in Hepatology and 14 papers in Infectious Diseases. Recurrent topics in Shahnaz Sali's work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (15 papers). Shahnaz Sali is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (15 papers). Shahnaz Sali collaborates with scholars based in Iran, Iraq and United States. Shahnaz Sali's co-authors include Seyed Moayed Alavian, Soheil Tavakolpour, Behzad Hajarizadeh, Esmail Riahi, Davood Yadegarynia, Masoud Mardani, Bita Behnava, Muayad Aghali Merza, Alireza Abrishami and Navid Mohammadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and Immunology Letters.

In The Last Decade

Shahnaz Sali

39 papers receiving 271 citations

Peers

Shahnaz Sali

EPIDE

HEPAT

IMMUN

Cristina Díez Spain

Paola Zuccalà Italy

Jenny Bischoff Germany

Pierluigi Blanc Italy

N. Maàmouri Tunisia

Susana López Argentina

Débora Raquel Benedita Terrabuio Brazil

Katharina Willuweit Germany

Tiziana Tieghi Italy

Mario Magnone United States

Cristina Díez Spain

Shahnaz Sali

225 ×1.2

EPIDE

167 ×1.1

HEPAT

92 ×1.5

45 ×1.6

IMMUN

8 ×0.3

Citations per year, relative to Shahnaz Sali Shahnaz Sali (= 1×) peers Cristina Díez

Countries citing papers authored by Shahnaz Sali

Since Specialization

Citations

This map shows the geographic impact of Shahnaz Sali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahnaz Sali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahnaz Sali more than expected).

Fields of papers citing papers by Shahnaz Sali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahnaz Sali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahnaz Sali. The network helps show where Shahnaz Sali may publish in the future.

Co-authorship network of co-authors of Shahnaz Sali

This figure shows the co-authorship network connecting the top 25 collaborators of Shahnaz Sali. A scholar is included among the top collaborators of Shahnaz Sali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahnaz Sali. Shahnaz Sali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yadegarynia, Davood, et al.. (2024). Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18–60 years: A double-blind, non-inferiority, randomized controlled trial. Vaccine. 42(9). 2254–2259. 1 indexed citations

Sali, Shahnaz, et al.. (2021). Impact of COVID-19 on 75 Immunocompromised Patients: Does Immunosuppression Alter the Clinical Course?. 7(2). 129–140.

Sali, Shahnaz, et al.. (2019). Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis. Journal of Clinical and Translational Hepatology. X(X). 1–16. 12 indexed citations

Sali, Shahnaz, et al.. (2018). Isolated Retrobulbar Hydatid Cyst: A Case Report. SHILAP Revista de lepidopterología. 1 indexed citations

Sali, Shahnaz, et al.. (2018). Chronic Hepatitis C, Genotyping, Metabolic Status and Body Mass Index in Iranian Population. 2(1).

Sali, Shahnaz, et al.. (2017). Assessment of Risk Factors in Patients with Chronic Hepatitis B Referred to Dr. Labbafi Nejad’s Hospital Hepatitis Clinic 2012-2014. SHILAP Revista de lepidopterología. 1 indexed citations

Sali, Shahnaz, et al.. (2017). Seroprevalence of Hepatitis a in Hemodialysis Patient Candidate for Kidney Transplant Younger Than Forty Years. SHILAP Revista de lepidopterología. 1 indexed citations

Tavakolpour, Soheil, et al.. (2017). Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy. Immunology Letters. 190. 206–212. 6 indexed citations

Sali, Shahnaz, et al.. (2016). Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus. Journal of Clinical and Translational Hepatology. 4(4). 306–309. 6 indexed citations

10.

Tavakolpour, Soheil, Seyed Moayed Alavian, & Shahnaz Sali. (2016). Manipulation of Regulatory Cells’ Responses to Treatments for Chronic Hepatitis B Virus Infection. Hepatitis Monthly. 16(6). e37927–e37927. 7 indexed citations

11.

Yadegarynia, Davood, et al.. (2016). Multiple intracranial tuberculomas in a post-kidney transplant patient. Saudi Journal of Kidney Diseases and Transplantation. 27(1). 135–135. 2 indexed citations

12.

Sali, Shahnaz, et al.. (2015). Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?. Diagnostic Microbiology and Infectious Disease. 82(2). 114–119. 6 indexed citations

13.

Sali, Shahnaz, et al.. (2015). Seroclearance of Hbsag in Chronic Hepatitis B Virus Patients on Lamivudine Therapy: A 10 Year Experience. Global Journal of Health Science. 7(6). 101–7. 2 indexed citations

14.

Sali, Shahnaz, et al.. (2014). Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B. Hepatitis Monthly. 14(2). e14228–e14228. 24 indexed citations

15.

Sali, Shahnaz, et al.. (2013). Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up. Hepatitis Monthly. 13(7). e8743–e8743. 11 indexed citations

16.

Yadegarynia, Davood, et al.. (2013). A rare case presentation of oral actinomycosis. SHILAP Revista de lepidopterología. 2(3). 187–189. 7 indexed citations

17.

Sali, Shahnaz, et al.. (2012). Real Response to Therapy in Chronic Hepatitis C Virus Patients: A Study From Iran. Hepatitis Monthly. 12(9). e6151–e6151. 23 indexed citations

18.

Sali, Shahnaz, Seyed Moayed Alavian, & Behzad Hajarizadeh. (2008). Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. Nephrology. 13(5). 376–379. 21 indexed citations

19.

Sali, Shahnaz, et al.. (2005). Risk Factors in Chronic Hepatitis B Infection: A Case-control Study. Hepatitis Monthly. 2005(4). 109–115. 36 indexed citations

20.

Sali, Shahnaz, Masoud Ahmadzad-Asl, & Seyed Moayed Alavian. (2004). Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report. Hepatitis Monthly. 4(6). 17–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact